Functional studies also indicated opposing effects of CB1R and CB2R, with CB2R activation consistently showing positive lipid metabolic outcomes, such as preventing obesity, nonalcoholic fatty liver disease, and diabetes [32, 33, 34]. The gene discussed is CNR1; the disease is obesity disorder.